Ropivacaine Hydrochloride Injection, Solution
Product Images NDC 0143-9195

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ropivacaine Hydrochloride (NDC 0143-9195). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula Structure (Ropivacaine Hydrochloride Injection 1)

FDA Label Image

Ropivacaine 200 mg Bag Label (Ropivacaine Hydrochloride Injection 2)

Ropivacaine 200 mg Bag Label (Ropivacaine Hydrochloride Injection 2)
This is a pharmaceutical product labeled as Ropivacaine Hydrochloride Injection, USP for epidural administration only. Each mL contains 2 mg of Ropivacaine HCI and 8.6 mg of sodium chloride. It is sterile, single-use only, and should be used immediately after opening. The recommended storage temperature is between 20°C to 25°C. The medication contains no preservatives and is not for intravenous administration. The package insert should be consulted for the usual dosage. The manufacturer is Hikma Pharmaceuticals USA Inc. from Berkeley Heights, NJ. It is not made with natural rubber latex or polyvinyl chloride.*
FDA Label Image

Ropivacaine 400 mg Bag Label (Ropivacaine Hydrochloride Injection 3)

Ropivacaine 400 mg Bag Label (Ropivacaine Hydrochloride Injection 3)
This text is a description of a prescription medication called Ropivacaine Hydrochloride Injection, used for infiltration, nerve block, and epidural administration only. It should not be used for intravenous administration and contains 2 mg of Ropivacaine HCI and 8.6 mg of sodium chloride per mL. The solution is sterile, pH-adjusted, and has no preservatives. It should be discarded after single use and is recommended for continuous infiltration or epidural infusion. The dosage information can be found in the package insert. The medication should be stored at controlled room temperature. The container is latex and PVC-free. Made by Hikma Pharmaceuticals USA Inc. in Italy.*
FDA Label Image

Ropivacaine 500 mg Bag Label (Ropivacaine Hydrochloride Injection 4)

Ropivacaine 500 mg Bag Label (Ropivacaine Hydrochloride Injection 4)
This is a prescription drug labeled as Ropivacaine Hydrochloride Injection, USP intended for infiltration, nerve block, and regional anesthesia. Each mL contains 5 mg of Ropivacaine HCI and 7.8 mg of sodium chloride. The pH is adjusted to 4.0 to 6.0. It is not for intravenous administration and should be discarded after single use. The drug does not contain preservatives and the container is latex and PVC-free. The manufacturer is Hikma Pharmaceuticals USA located in Berkeley Heights, NJ. It is stored at 20°C to 25°C and is for single-use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.